DOCSLIB.ORG

Spectra Library Index SDBS Library

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Spectra Library Index SDBS Library S p e c t r a L i b r a r y I n d e x SDBS Library KBr ライブラリー名：スタンダードライブラリーKBr 商品番号：40001-40 株式会社 エス・ティ・ジャパン 〒103-0014 東京都中央区日本橋蛎殻町 1-14-10 Tel: 03-3666-2561 Fax:03-3666-2658 http://www.stjapan.co.jp 1 【販売代理店】（株）テクノサイエンス Tel：043-206-0155Fax：043-206-0188 http://www.techno-lab-co.jp/ (((3,4-DIHYDROXY-9,10-DIOXO-9,10-DIHYDRO-2-ANTHRYL)METHYL)IMINO)DIACETIC ACID (((N-BENZYLOXYCARBONYL-L-PHENYLALANYL)-O-ACETYL-L-THREONYL)-L-PROLYL-L-PHENYLALANYL)-N(OMEGA)-NITRO-L-ARGININE 4-NITROBENZYL ESTER ((1,2-DIETHYLETHYLENE)BIS(P-PHENYLENE))DIACETATE ((1-BENZOTRIAZOLYL)OXY)TRIS(DIMETHYLAMINO)PHOSPHONIUM HEXAFLUOROPHOSPHATE ((2-(3-BENZYLSULFONYL-4-METHYLCYCLOHEXYL)PROPYL)SULFONYLMETHYL)BENZENE ((2,4,6-TRIOXOHEXAHYDRO-5-PYRIMIDINYL)IMINO)DIACETIC ACID ((2-BENZOTHIAZOLYL)AMINOMETHYLENE)MALONONITRILE ((2-CARBOXYETHYL)IMINO)DIACETIC ACID ((2-CYANOETHYLAMINO)(3-INDOLYL)METHYLENE)MALONONITRILE ((2-HYDROXYETHYL)IMINO)DIACETIC ACID ((2-HYDROXYETHYLAMINO)(3-INDOLYL)METHYLENE)MALONONITRILE ((2-NITROBENZYL)IMINO)DIACETIC ACID ((2-OXOPROPYL)IMINO)DIACETIC ACID ((2-PYRIDYLAMINO)METHYLENE)MALONONITRILE ((2-QUINOLINYL)AMINOMETHYLENE)MALONONITRILE ((2-SULFOETHYL)IMINO)DIACETIC ACID ((2-THIAZOLYLAMINO)METHYLENE)MALONONITRILE ((3-(1-BROMO-1-METHYLETHYL)-7-OXO-1,3,5-CYCLOHEPTATRIEN-1-YL)OXY)DIFLUOROBORANE ((3-INDOLYL)(1-PYRROLIDINYL)METHYLENE)MALONONITRILE ((3-INDOLYL)(METHYLTHIO)METHYLENE)MALONONITRILE ((3-INDOLYL)MORPHOLINOMETHYLENE)MALONONITRILE ((3-INDOLYL)PIPERIDINOMETHYLENE)MALONONITRILE ((3-METHYL-2-PYRIDYLAMINO)METHYLENE)MALONONITRILE ((4-METHYL-2-PYRIDYLAMINO)METHYLENE)MALONONITRILE 2 ((4-NITROBENZYL)IMINO)DIACETIC ACID ((5-ISOPROPYL-2-METHYLCYCLOHEXYL)SULFONYLMETHYL)BENZENE ((5-METHYL-2-PYRIDYLAMINO)METHYLENE)MALONONITRILE ((6-METHYL-2-PYRIDYL)AMINOMETHYLENE)MALONONITRILE ((AZULENO(2,1-B)THIOPHEN-9-YL)METHYLENE)MALONONITRILE ((DIPHENYLMETHYLENE)AMINO)ACETONITRILE ((N-(2-CYANOETHYL)-N-METHYLAMINO)(3-INDOLYL)METHYLENE)MALONONITRILE ((N,N-DIMETHYLTHIOCARBAMOYL)THIO)ACETIC ACID ((N-BENZYLOXYCARBONYL-L-ISOLEUCYL)-L-PROLYL-L-PHENYLALANYL)-N(OMEGA)-NITRO-L-ARGININE 4-NITROBENZYL ESTER ((P-BROMOBENZOYLMETHYLTHIO)METHYLENE)DIMETHYLAMMONIUM BROMIDE ((PYRAZINYLAMINO)METHYLENE)MALONONITRILE (-)-(1A,2B,5A)-2-ISOPROPYL-5-METHYLCYCLOHEXYL (1-NAPHTHYL)CARBAMATE (-)-(1A,2B,5A)-2-ISOPROPYL-5-METHYLCYCLOHEXYL 3,5-DINITROBENZOATE (-)-(1A,2B,5A)-2-ISOPROPYL-5-METHYLCYCLOHEXYL P-TOLUENESULFONATE (-)-(2S,8AR)-(CAMPHORSULFONYL)OXAZIRIDINE (-)-(6R,7R)-7-((Z)-2-(2-AMINO-4-THIAZOLYL)-2-HYDOXYIMINO-ACETAMIDO)-8-OXO-3-VINYL-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID (-)-1-(4-ACETOXYBENZYL)-7-BENZYLOXY-6-METHOXY-2-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE COMPD. WITH 2,3-BIS(P-METHYLBENZOYLOXY)SUCCINIC A (-)-1,4-DI-O-TOSYL-2,3-O-ISOPROPYLIDENE-L-THREITOL (-)-1,6,6-TRIMETHYL-1,2,6,7,8,9-HEXAHYDROPHENANTHRO(1,2-B)FURAN-10,11-DIONE (-)-1,6-BIS(O-CHLOROPHENYL)-1,6-DIPHENYL-2,4-HEXADIYNE-1,6-DIOL (-)-10-CAMPHORSULFONYL CHLORIDE (-)-2-(2,4,5,7-TETRANITRO-9-FLUORENYLIDENEAMINOOXY)PROPIONIC ACID (-)-2-(2-HYDROXY-4-METHYLCYCLOHEXYL)ACRYLALDEHYDE SEMICARBAZONE (-)-2,10-CAMPHORSULTAM 3 (-)-2,3-O-ISOPROPYLIDENE-2,3-DIHYDROXY-1,4-BIS(DIPHENYLPHOSPHINO)BUTANE (-)-2,3-O-ISOPROPYLIDENE-D-THREITOL (-)-2-AMINO-6-MERCAPTOPURINE RIBOSIDE (-)-2'-DEOXYINOSINE (-)-3',5'-O-(1,1,3,3-TETRAISOPROPYL-1,3-DISILOXANEDIYL)ADENOSINE (-)-3B-HYDROXY-5A-CHOLESTAN-6-ONE (-)-3-P-MENTHYL CROTONATE (-)-3-UREIDO-L-ALANINE (-)-4-(1-HYDROXY-2-(ISOPROPYLAMINO)ETHYL)-1,2-BENZENEDIOL HYDROGEN (+)-TARTRATE (-)-4-ISOPROPENYL-1-CYCLOHEXENE-1-CARBALDEHYDE 2,4-DINITROPHENYLHYDRAZONE (-)-4-ISOPROPENYL-1-CYCLOHEXENE-1-CARBALDEHYDE SEMICARBAZONE (-)-5-ANDROSTENE-3B,17B-DIOL (-)-5-METHYL-5-VINYL-2,4-IMIDAZOLIDINEDIONE (-)-6-AZAURIDINE 2',3',5'-TRIACETATE (-)-6-BROMO-2-NAPHTHYL B-D-GLUCOPYRANOSIDURONIC ACID (-)-ADENOSINE 3',5'-CYCLIC MONOPHOSPHATE (-)-BENZYLMETHYLPHENYLSILYLACETIC ACID (-)-BENZYLOXYCARBONYL-L-ETHOXYASPARTOYL-L-ETHOXYASPARTIC ACID ETHYL ESTER (-)-BENZYLOXYCARBONYL-L-METHOXYGLUTAMOYL-L-METHOXYGLUTAMIC ACID METHYL ESTER (-)-BENZYLOXYCARBONYL-L-PHENYLALANYL-L-PHENYLALANINE ETHYL ESTER (-)-BIS(BIGUANIDE)(ETHYLENEDIAMINE)COBALT(III) TRICHLORIDE (-)-CIS-3,4-DIMETHYL-2-PHENYLTETRAHYDRO-1,4-THIAZINE HYDROCHLORIDE (-)-DIACETYL-L-TARTARIC ACID (-)-DIBENZOYL-L-TARTARIC ACID 4 (-)-DIMETHYL TRANS-3,3-DIMETHYL-1,2-CYCLOPROPANEDICARBOXYLATE (-)-DI-P-TOLUOYL-L-TARTARIC ACID (-)-EBURNAMONINE (-)-EPICATECHIN (-)-ERYTHROMYCIN (-)-KAURENE (-)-MENTHOL (-)-MENTHOXYACETIC ACID (-)-METHYL B-D-ARABINOPYRANOSIDE (-)-N-(1-HYDROXYMETHYL-2-METHYLBUTYL)ACETAMIDE (-)-N(6)-FURFURYLADENOSINE (-)-N(6)-METHYLADENOSINE (-)-N-(A-PHENYLPHENETHYL)METHACRYLAMIDE (-)-N,N'-DIBENZYL-D-TARTRAMIDE (-)-NOE-LACTOL DIMER (-)-O-METHYLTYROSINE (-)-P-NITROPHENYL B-D-GALACTOPYRANOSIDE (-)-TRANS-A,A'-(2,2-DIMETHYL-1,3-DIOXOLANE-4,5-DIYL)BIS(DIPHENYLMETHANOL) (+)-(1A,2B,5A)-2-ISOPROPYL-5-METHYLCYCLOHEXYL P-TOLUENESULFONATE (+)-(2R,8AS)-(CAMPHORSULFONYL)OXAZIRIDINE (+)-1,6-BIS(O-CHLOROPHENYL)-1,6-DIPHENYL-2,4-HEXADIYNE-1,6-DIOL (+)-10-CAMPHORSULFONIC ACID (+)-10-CAMPHORSULFONYL CHLORIDE (+)-17B-HYDROXY-5A-ANDROSTAN-3-ONE BENZOATE 5 (+)-2-(2,4,5,7-TETRANITRO-9-FLUORENYLIDENEAMINOOXY)PROPIONIC ACID (+)-2-(ETHYLAMINO)-3-PHENYLPROPANOL (+)-2,10-CAMPHORSULTAM (+)-2,3-O-ISOPROPYLIDENE-2,3-DIHYDROXY-1,4-BIS(DIPHENYLPHOSPHINO)BUTANE (+)-2,3-O-ISOPROPYLIDENE-L-THREITOL (+)-2-AMINO-4-(PHENYLACETAMIDO)BUTYRIC ACID (+)-2-ISOPROPENYL-5-METHYLCYCLOHEXYL HYDROGEN SELENITE (+)-3,3-DIMETHYL-1,TRANS-2-BIS(MORPHOLINOTHIOCARBONYL)CYCLOPROPANE (+)-3',5'-O-(1,1,3,3-TETRAISOPROPYL-1,3-DISILOXANEDIYL)CYTIDINE (+)-4-(2-CHLOROETHOXY)-4'-(2-METHYLBUTYL)AZOBENZENE (+)-4-(2-CHLOROETHOXY)-4'-(2-METHYLBUTYL)-NNO-AZOXYBENZENE (+)-4-(2-METHYLBUTOXY)-4'-(2-METHYLBUTYL)AZOBENZENE (+)-4-(2-METHYLBUTOXY)-4'-(2-METHYLBUTYL)-NNO-AZOXYBENZENE (+)-4'-(2-METHYLBUTOXY)-4-BIPHENYLCARBONITRILE (+)-4-(2-METHYLBUTYL)-4'-(PENTYLOXY)AZOBENZENE (+)-4-(2-METHYLBUTYL)-4'-PENTYLOXY-ONN-AZOXYBENZENE (+)-4,4,8-TRIMETHYL-1,2,3,4,8,9-HEXAHYDROPHENANTHRO(3,2-B)FURAN-7,11-DIONE (+)-4,4'-BIS(2-METHYLBUTOXY)AZOBENZENE (+)-4,4'-BIS(2-METHYLBUTOXY)AZOXYBENZENE (+)-4,4'-BIS(2-METHYLBUTYL)AZOBENZENE (+)-4,4'-BIS(2-METHYLBUTYL)AZOXYBENZENE (+)-4-ETHOXY-4'-(2-METHYLBUTOXY)AZOBENZENE (+)-4-ETHOXY-4'-(2-METHYLBUTOXY)-NNO-AZOXYBENZENE (+)-4-ETHOXY-4'-(3-METHYLPENTYL)AZOBENZENE 6 (+)-4-HEPTYLOXY-4'-(2-METHYLBUTYL)AZOBENZENE (+)-4-HEPTYLOXY-4'-(2-METHYLBUTYL)-NNO-AZOXYBENZENE (+)-4-METHOXY-4'-(2-METHYLBUTOXY)AZOBENZENE (+)-4-METHOXY-4'-(2-METHYLBUTOXY)-NNO-AZOXYBENZENE (+)-4-METHOXY-4'-(2-METHYLBUTYL)AZOBENZENE (+)-4-METHOXY-4'-(2-METHYLBUTYL)-NNO-AZOXYBENZENE (+)-5-BROMO-2'-DEOXYURIDINE (+)-7',12'-DIHYDROXY-6,6'-DIMETHOXY-2,2',2'-TRIMETHYLTUBOCURARANIUM CHLORIDE HYDROCHLORIDE (+)-8-HYDROXY-4,5,6,7-TETRAMETHYL-1,3-ISOCHROMANDIONE (+)-A,N-DIMETHYLBENZYLAMINE (-)-A,N-DIMETHYLBENZYLAMINE 2,3-BIS(BENZOYLOXY)SUCCINIC ACID (+)-AMMONIUM 3-BROMO-8-CAMPHORSULFONATE (+)-AMYLOSE (+)-ARABINOGALACTAN (+)-BICUCULLINE (+)-BIOTIN P-NITROPHENYL ESTER (+-)-BORNEOL (+)-CAMPHOR (+)-CAMPHOR OXIME (+)-CAMPHORIC ACID (+)-CAMPHORIC ANHYDRIDE (+)-CATECHIN (+)-CYMARIN (+)-DIBENZOYL-D-TARTARIC ACID (+)-DI-P-TOLUOYL-D-TARTARIC ACID 7 (+)-GLAUCINE (+)-G-L-GLUTAMYL-L-GLUTAMIC ACID (+)-GRISEOFULVIN (+)-ISOMENTHOL (+)-ISOPHYLLOCLADENE (+)-MURAMIC ACID (+)-N(2)-ACETYL-L-LYSINE (+)-N(A)-ACETYL-L-TRYPTOPHANAMIDE (+)-N-(N-ACETYL-L-PHENYLALANYL)-3,5-DIIODO-L-TYROSINE (+)-N-(P-(2-METHYLBUTOXY)BENZYLIDENE)-4-(2-METHYLBUTYL)ANILINE (+)-N,2-DIPHENYLPROPIONAMIDE (+)-N-ACETYLMURAMIC ACID (+)-NICOTINE(+)-DI-P-TOLUOYLTARTRATE SALT (+)-NOE-LACTOL DIMER (+)-P-((P-(2-METHYLBUTYL)PHENYL)IMINOMETHYL)BENZONITRILE (+)-P-(4-(2-METHYLBUTYL)BENZYLIDENEAMINO)BENZONITRILE (+)-P-(HEXYLOXY)PHENYL P-(2-METHYLBUTYRYLOXY)BENZOATE (+)-P-(P-(2-METHYLBUTYL)PHENYLAZO)BENZONITRILE (+)-P-(P-(2-METHYLBUTYL)PHENYLAZO)PHENOL (+)-P-(P-(2-METHYLBUTYL)PHENYL-ONN-AZOXY)BENZONITRILE (+)-P-PENTYLPHENYL 2-CHLORO-4-(P-(2-METHYLBUTYL)BENZOYLOXY)BENZOATE (+)-P-PENTYLPHENYL 2-METHYL-4-(P-(2-METHYLBUTYL)BENZOYLOXY)BENZOATE (+)-S-(P-(HEXYLOXY)PHENYL) P-(2-METHYLBUTYL)(THIOBENZOATE) (+)-S-(P-BUTOXYPHENYL) P-(2-METHYLBUTYL)THIOBENZOATE 8 (+)-STIGMASTAN-3B-OL (+)-TRANS-1-ISOPROPYL-1,2-CYCLOPROPANEDICARBOXYLIC ACID (+)-TRANS-A,A'-(2,2-DIMETHYL-1,3-DIOXOLANE-4,5-DIYL)BIS(DIPHENYLMETHANOL) (+/-)-(2-(1,4-DIMETHYL-2,5-DIOXO-4-IMIDAZOLIDINYL)ETHYL)TRIMETHYLAMMONIUM IODIDE (+/-)-(2-BROMO-5-OXO-2,5-DIHYDRO-2-FURYL)METHYL BENZOATE (+/-)-(2-METHYL-3-PHENYLPROPYL)MALONIC ACID (+/-)-(B-HYDROXY-A-METHYLPHENETHYL)TRIMETHYLAMMONIUM IODIDE (+/-)-1-(1-NAPHTHYL)-1,2-ETHANEDIOL (+/-)-1-(3,4-DIHYDROXYBENZYL)-2-METHYL-1,2,3,4-TETRAHYDRO-6,7-ISOQUINOLINEDIOL HYDROBROMIDE (+/-)-1-(P-NITROPHENYL)-3,5-DIPHENYLDIHYDRO-1H,3H,5H-OXAZOLO(3,4-C)OXAZOLE (+/-)-1,2,3,4-TETRACHLOROBUTANE (+/-)-1,2-DIPHENYL-1,2-ETHANEDIOL (+/-)-1,2-DITHIOLANE-3-VALERAMIDE (+/-)-1,2-DODECANEDIOL (+/-)-1,3-DIPHENYL-1,3-PROPANEDIOL (+/-)-1,4-DIPHENYL-1,4-BUTANEDIOL (+/-)-10-CAMPHORSULFONIC ACID (+/-)-1-BENZYL-1-(A-METHYLBENZYL)HYDRAZINE PICRATE (+/-)-2-(2-FLUORO-4-BIPHENYLYL)PROPIONIC ACID (+/-)-2-(4-CHLORO-A-(2-PIPERIDINOETHYL)BENZYL)PYRIDINE MALEATE (+/-)-2-(4-METHYL-3-NITROSO-4-PIPERIDINOCYCLOHEXYL)-2-PROPANOL (+/-)-2-(BENZYLAMINO)BUTYL HYDROGEN SULFATE (+/-)-2-(BENZYLAMINO)PROPIOPHENONE HYDROCHLORIDE (+/-)-2-(P-CHLOROPHENOXY)PROPIONIC ACID 9 (+/-)-2,2,5,5-TETRAMETHYL-4-THIAZOLIDINECARBOXYLIC ACID HYDROCHLORIDE (+/-)-2,3,4,5,6-PENTAFLUORO-A-METHYLBENZYL ALCOHOL (+/-)-2,3-DIAMINOPROPIONIC ACID HYDROCHLORIDE (+/-)-2,4-DIHYDROXY-N-(3-HYDROXYPROPYL)-3,3-DIMETHYLBUTYRAMIDE (+/-)-2-ACETAMIDO-2-METHYL-2-PHENYLPROPIONIC ACID (+/-)-2-ACETAMIDO-4-MERCAPTOBUTYRIC ACID G-THIOLACTONE
Load more

Recommended publications
  • United States Patent Office 3,350,427 Patented Oct
    United States Patent Office 3,350,427 Patented Oct. 31, 1967 1. 2 3,358,427 By lower alkyl is contemplated hydrocarbon radicals PROCESS FOR THE DEHYDROHALOGENATION having preferably up to four carbon atoms including CF SEROADS methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, and WilliamOrange, H. N.J., Gebert, assignors Morris to ScheringPaias, and Corporation, Nathaniel Murrill, Bloom tertiary butyl. field, N.Y., a corporation of New Jersey Our process is particularly valuable when it is desired No Drawing. Fied Jan. 28, 1966, Ser. No. 523,573 to dehydrobrominate a 17-bromo-20-keto-steroid having 10 Claims. (C. 260-397.4) at least one hydrogen at C-16, e.g. 16oz - methyl - 17 oz bromo-5-pregnen-3,6-ol-20-one or the 3-acetate thereof to This invention relates to a novel improved process for the corresponding 16-dehydro-20-keto-steroid, e.g. 5, 16 dehydrohalogenating organic compounds. O pregnadien-36-ol-20-one or the 3-acetate thereof, which In general, the invention sought to be patented is de are known, valuable intermediates in the preparation of scribed as residing in the concept of treating an o-bromo other known therapeutically valuable compounds. For ketone having a hydrogen on the beta carbon with a example, 16-methyl - 5, 16 - pregnadien-3 (3-ol-20-one may dehydrchalogenating agent selected from the group con be catalytically hydrogenated to provide 166-methyl-5- sisting of an alkaline earth oxide, an alkaline earth hy 5 pregnen-36 - ol - 20-one which may be oxidized to 16,3- droxide, and mixtures thereof in a solvent Selected from methylprogesterone.
    [Show full text]
  • WO 2008/096257 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date PCT (10) International Publication Number 14 August 2008 (14.08.2008) WO 2008/096257 Al (51) International Patent Classification: 500038 (IN). BURIDIPADU, Sunil Kumar [IN/IN]; C07D 239/42 (2006.01) Aurobindo Pharma Limited, Plot No.2, Maitrivihar, Ameerpet, Andhra Pradesh, Hyderabad 500038 (IN). (21) International Application Number: MEENAKSHISUNDERAM, Sivakumaran [IN/IN]; PCT/IB2008/000290 Aurobindo Pharma Limited, Plot No.2, Maitrivihar, Ameerpet, Andhra Pradesh, Hyderabad 500038 (IN). (22) International Filing Date: 4 February 2008 (04.02.2008) (81) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of national protection available): AE, AG, AL, AM, AO, AT,AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, (26) Publication Language: English CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, (30) Priority Data: IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, 277/CHE/2007 8 February 2007 (08.02.2007) IN LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, 1121/CHE/2007 29 May 2007 (29.05.2007) IN MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, (71) Applicant (for all designated States except US): AU- SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ROBINDO PHARMA LIMITED [IN/IN]; Plot No.2, ZA, ZM, ZW Maitrivihar, Ameerpet, Andhra Pradesh, Hyderabad 500038 (IN).
    [Show full text]
  • A Thesis Entitled "APPLICATIONS of GAS CHROMATOGRAPHY
    A Thesis entitled "APPLICATIONS OF GAS CHROMATOGRAPHY - MASS SPECTROMETRY IN STEROID CHEMISTRY" Submitted in part fulfilment of the requirements for admittance to the degree of Doctor of Philosophy in The University of Glasgow by T.A. Baillie, B.Sc. University of Glasgow 1973. ProQuest Number: 11017930 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 11017930 Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 ACKNOWLEDGEMENTS I would like to express my sincere thanks to Dr. C.3.W. Brooks for his guidance and encouragement at all times, and to Professors R.A. Raphael, F.R.S., and G.W. Kirby, for the opportunity to carry out this research. Thanks are also due to my many colleagues for useful discussions, and in particular to Dr. B.S. Middleditch who was associated with me in the work described in Section 3 of this thesis. The work was carried out during the tenure of an S.R.C. Research Studentship, which is gratefully acknowledged. Finally, I would like to thank Miss 3.H.
    [Show full text]
  • The Development of Simplified Microreactors for Use in Multi-Step Reaction Sequences
    THE DEVELOPMENT OF SIMPLIFIED MICROREACTORS FOR USE IN MULTI-STEP REACTION SEQUENCES A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Andrew R. Bogdan August 2009 © 2009 Andrew R. Bogdan THE DEVELOPMENT OF SIMPLIFIED MICROREACTORS FOR USE IN MULTI-STEP REACTION SEQUENCES Andrew R. Bogdan, Ph. D. Cornell University 2009 This dissertation describes the development of simplified microreactors to be used in multi-step reaction sequences. Microreactors are a developing technology with numerous benefits and whose modular design permits multi-step reaction sequences to be performed in a continuous flow process. The first chapter discusses the physical properties of microreactors and describes how performing reactions in these miniaturized reactors leads to safer, more efficient and more selective chemical transformations. A brief discussion of multi-step reaction sequences already performed in flow will also be presented. These multi-step reaction sequences, however, rarely rely on catalysis to facilitate chemical transformations. This area therefore has room for great improvement. The next two chapters discuss the development and application of solid-supported catalysts to be used in flow. In the first of these two chapters, two catalysts are immobilized on a solid-support and used in a simplified flow reactor. These reactions proved to be more efficient than similar batch reaction and the catalysts were highly recyclable. The next chapter presents a supported TEMPO catalyst used to oxidize alcohols to carbonyl species. These three catalysts set the foundation for multi-step flow reaction to be potentially performed in the group.
    [Show full text]
  • United States Patent Office Paterated Feb
    3,306,895 United States Patent Office Paterated Feb. 28, 1967 1. 2 3,306,895 The compounds of this invention are obtained by treat HETEROCYCLIC DERVATIVES OF TRPHENYL ment of triphenylethylene derivatives of the type: , ETHYLENES, TRIPHENYLETHANES AND TRI PHENYLETHANOLS Edward McCreery Roberts, George Philip Claxton, and 5 Frances Gertrude Fallon, Cincinnati, Ohio, assignors to Richardson-Merrell Inc., New York, N.Y., a corpo ration of Delaware No Drawing. Filed June 27, 1962, Ser. No. 205,551 10 Claims. (C. 260-240) k This invention relates to a series of novel and useful O where R and R' are as previously defined, with an ap compounds and processes for preparing the same. More propriate organometallic derivative such as cy-picolyl particularly, this invention relates to a series of triphenyl lithium (as in Examples 2 and 5), 3-pyridyl lithium (as ethanes, triphenylethylenes, and triphenylethanols, in in Example 6), or 2-pyridyl lithium (as in Examples 1 which one of the phenyl groups is substituted with a pyri and 4). Such treatment is conveniently carried out by dyl or reduced pyridyl ring which is separated from the mixing the reactants in an inert solvent such as ether, aromatic portion of the molecule by an oxygenated alkyl benzene, toluene, or combinations of such inert solvents fragment of one, two or three carbon atoms. The inven at appropriate temperatures chosen in the range of tion also includes nontoxic, water-soluble addition salts, -60° C. to 80° C. The resulting imine is hydrolyzed to quaternary ammonium derivatives and N-oxide deriva the corresponding ketone without being isolated by being tives of the new compounds.
    [Show full text]
  • Benzopinacolate Promoted Radical Carbon-Carbon Bond Forming
    Bis(trimethylstannyl)benzopinacolate Promoted Radical Carbon-Carbon Bond Forming Reactions and Related Studies Dissertation Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Franklin Lee Seely Graduate Program in Chemistry The Ohio State University 2010 Dissertation Committee: Robert S. Coleman, Co-Advisor David J. Hart, Co-Advisor T. V. RajanBabu Abstract This research has dealt primarily with the development of novel methods for radical carbon-carbon bond formation. A major focus of this research has been the hydrogen atom free generation of trialkyltin radicals. The bulk of this thesis will deal with the use of bis(trimethylstannyl)benzopinacolate 1 in mediating radical reactions. We have demonstrated that these conditions allow a wide variety of inter and intramolecular free radical addition reactions. We have given evidence that these reactions proceed via a novel non-chain free radical mechanism. ii Dedication This thesis is dedicated to Tracy Lynne Court. You have given me the courage to try again. iii Acknowledgments I would like to sincerely thank Dr. David J. Hart for all his help, the countless hours of work he put in, and for making this possible. I would like to thank Dr. Robert S. Coleman for agreeing to act as my advisor, and all the support and guidance he has given. I would like to than Dr. T. V. RajanBabu for reading my thesis and all his thoughtful suggestions. iv Vita Education 1981-1985 ………………………………………………………..B.S., The University
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,800,658 B2 Brugnara Et Al
    USOO6800658B2 (12) United States Patent (10) Patent No.: US 6,800,658 B2 Brugnara et al. (45) Date of Patent: Oct. 5, 2004 (54) SUBSTITUTED DIPHENYL INDANONE, 5,273,992 A 12/1993 Brugnara et al. ........... 514/398 NDANE AND INDOLE COMPOUNDS AND 5,358,959 A 10/1994 Halperin et al. ...... ... 514/396 ANALOGUES THEREOF USEFUL FOR THE 5,430,062 A 7/1995 Cushman et al. ..... ... 514/646 5,512.563 A * 4/1996 Albright et al. ............ 514/217 TREATMENT OF PREVENTION OF 2002/0128256 A1 * 9/2002 Brugnara et al. ...... 514/212.02 DISEASES CHARACTERIZED BY ABNORMAL CELL PROLIFERATION FOREIGN PATENT DOCUMENTS (75) Inventors: Carlo Brugnara, Newton Highlands, DE 37O6427 9/1988 DE 1OOO4654 8/2001 MA (US); Jose Halperin, Brookline, EP O323 740 A2 7/1989 MA (US); Rudolf Fluckiger, Brookline, EP 483632 5/1992 MA (US); Emile M. Bellott, Jr., EP O 583 665 A2 2/1994 Beverly, MA (US); Richard John EP O 636 608 A1 2/1995 Lombardy, Littleton, MA (US); John JP OS 58894 3/1993 J. Clifford, Arlington, MA (US); JP OSOSO771 3/1993 Ying-Duo Gao, Meshanie Station, NJ WO WO 89/08096 9/1989 (US); Reem M. Haidar, Woburn, MA WO WO95/26720 10/1995 (US); Eugene W. Kelleher, Somerville, WO WO 96/08240 3/1996 MA (US); Adel M. Moussa, WO WO 96/08242 3/1996 Burlington, MA (US); Yesh P. WO WO 96/36631 11/1996 Sachdeva, Concord, MA (US); WO WO 99/26624 6/1999 Minghua Sun, Cambridge, MA (US); WO WO O2/32465 4/2002 Heather N.
    [Show full text]
  • Iron-Catalysed Enantioconvergent Suzuki-Miyaura Cross-Coupling to Afford Enantioenriched 1,1-Diarylalkanes
    Electronic Supplementary Material (ESI) for Chemical Communications. This journal is © The Royal Society of Chemistry 2020 Iron-Catalysed Enantioconvergent Suzuki-Miyaura Cross-Coupling to Afford Enantioenriched 1,1-Diarylalkanes Chet C. Tyrol, Nang S. Yone, Connor F. Gallin, Jeffery A. Byers* Department of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02467, United States General Considerations .................................................................................................. 1 Synthetic Procedures ...................................................................................................... 3 Figure S1. Synthesis of cyano-bis(oxazoline) ligands and iron complexes ..................... 3 Synthesis of Diarylalkanes ............................................................................................. 18 Preparation of arylboronic pinacol esters ..................................................................... 30 Preparation of benzylic halides ...................................................................................... 31 Figure S2. Resubjection of enantiomerically-enriched product ......................................... 36 Table S1. Solvent and additive screen .............................................................................. 37 Table S2. Bis(oxazoline) ligand screen ............................................................................. 38 Table S3. Effect of catalyst loading ..................................................................................
    [Show full text]
  • ME Manning Et Al., Chem. Abstract 94.102538, 1981
    USOO6992O79B2 (12) United States Patent (10) Patent No.: US 6,992,079 B2 Brugnara et al. (45) Date of Patent: *Jan. 31, 2006 (54) SUBSTITUTED 4,006,023 A 2/1977 McLaughlin et al. ....... 96/90 R 11-PHENYL-DBENZAZEPINE COMPOUNDS 4,806,685 A 2/1989 Abraham et al. ........... 563/324 USEFUL FOR THE TREATMENT OR 5,273,992 A 12/1993 Brugnara et al. ..... ... 514/398 5,358,959 A 10/1994 Halperin et al. ...... ... 514/396 ERR2E, RMAL cell 5,430,062. A 7/1995 Cushman et al. ........... 514/646 5,512.563 A * 4/1996 Albright et al. ............ 514/217 PROLIFERATION 6,063,921 A 5/2000 Moussa et al. (75) Inventors: Carlo Brugnara, Newton Highlands, 6,291,4496,201,120 B1 9/20013/2001 Ms t alal. MA (US); Jose Halperin, Brookline, 6,534,497 B1 * 3/2003 Brugnara et al. ........... 514/217 MA (US); Rudolf Fluckiger, Brookline, 2001/0007030 A1 7/2001 Moussa et al. MA (US); Emile M. Bellott, Jr., Beverly, MA (US); Richard John FOREIGN PATENT DOCUMENTS Lombardy, Littleton, MA (US); John EP O 323 740 A2 7/1989 J. Clifford, Arlington, MA (US); EP O 583 665 A2 2/1994 Ying-Duo Gao, Edison, NJ (US); Reem EP O 636 608 A1 2/1995 M. Haidar, Woburn, MA (US); Eugene JP OS 58894 3/1993 W. Kelleher, Medford, MA (US); Adel WO WO95/26720 10/1995 M. Moussa, Burlington, MA (US); WO WO 96/08240 3/1996 Yesh P. Sachdeva, Concord, MA (US); W W 't f1. Minghua Sun, Libertyville, IL (US); Heather N.
    [Show full text]
  • Chemfiles 9.3 Cover.Indd 1 6/18/2009 7:49:52 AM Vol
    Vol. 9, No. 3 Chiral Building Blocks Features include: A–Z Product Listings Heterocyclic Building Blocks Organic Building Blocks (S)-(–)-Glycidol: chiral epoxide building block used in synthesis of many pharmaceuticals and natural products 70978 ChemFiles 9.3 cover.indd 1 6/18/2009 7:49:52 AM Vol. 9 No. 3 Introduction Asymmetric synthesis remains a challenge to synthetic chemists as Aldrich Chemical Co., Inc. the demand for enantiomerically pure compounds continues to Sigma-Aldrich Corporation increase. Whether the building blocks are used in the development 6000 N. Teutonia Ave. of new and exciting chiral auxiliaries, ligands, or for obtaining Milwaukee, WI 53209, USA advanced and enantiomerically enriched druglike molecules, research scientists continually need access to a vast array of novel chiral building blocks and architectures to achieve success. To Place Orders In this edition of ChemFiles, we have endeavored to provide a comprehensive listing of over 1000 chiral building blocks. Within Telephone 800-325-3010 (USA) each section of this issue, products are listed by increasing FAX 800-325-5052 (USA) carbon content. Introduction Mark Redlich Sigma-Aldrich is lists over 5000 chiral products for the successful Product Manager Customer & Technical Services construction of complex asymmetric architectures—for a complete listing of products related to chiral chemistry and asymmetric synthesis, please visit us at Customer Inquiries 800-325-3010 sigma-aldrich.com/chiral. If you are unable to find a product for Technical Service 800-231-8327 your research, “Please Bother Us” at [email protected] or contact your local SAFC® 800-244-1173 Sigma-Aldrich office.
    [Show full text]
  • Adsorption Behavior of the Primary, Secondary and Tertiary Alkyl, Allyl and Aryl Alcohols Over Nanoscale (1 0 0) Surface of Γ-Alumina
    Adsorption Behavior of the Primary, Secondary and Tertiary Alkyl, Allyl and Aryl Alcohols Over Nanoscale (1 0 0) Surface of γ-Alumina Mehdi Zamani1,2*, Hossein A. Dabbagh2* 1) Department of Chemistry, Malek-ashtar University of Technology, Shahin-shahr P.O. Box 83145/115, Islamic Republic of Iran 2) Department of Chemistry, Isfahan University of Technology, Isfahan 84156-83111, Islamic Republic of Iran Abstract In this study, the adsorption behavior of the primary, secondary and tertiary alcohols over nanoscale (1 0 0) surface of defect spinel γ-alumina was investigated with the aid of density functional theory (DFT) at BLYP/DNP level of calculation. The influence of different substituents including alkyl, cycloalkyl, allyl and aryl were analyzed for free and adsorbed alcohols to shed light the adsorption selectivity of these compounds over γ-alumina surface. These results indicate that more branches at position of alcohol favor the adsorption, while a decrease in adsorption energy is achieved for the alcohols containing the substituents at the β position. The tertiary alcohols are adsorbed over the surface stronger than secondary and primary alcohols. Alcohols with larger alkyl chains have greater adsorption energies. Also the aryl alcohols are adsorbed over the surface better than the alkyl and allyl moieties. Keywords: Nanoscale surface of γ-Alumina; Alcohol; Molecular adsorption; DFT © 2014 Published by Journal of Nanoanalysis. 1. Introduction Alumina is well known catalyst by both acidic and basic properties. In recent years, many experimental and theoretical works have studied the structure, reactivity and selectivity of γ-alumina especially at nanoscale (1-23). Theoretical investigations of the adsorption on γ-alumina have focused mostly on Lewis acidity of the surface (1-4), and the reactivity with water (5-11), hydrogen sulfide (5,10,12), carbon monoxide (5,10,13), ammonia (6), pyridine (4,6), hydrogen chloride (7), alkenes (14,15), alkanes (16), alcohols (17-23) and ethers (23).
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,349,977 B2 Koenig Et Al
    US008349977B2 (12) United States Patent (10) Patent No.: US 8,349,977 B2 Koenig et al. (45) Date of Patent: Jan. 8, 2013 (54) PROCESS FOR PREPARING W. W338 A .289 SETITY ISOBUTENE HOMO- OR WO WO 2010, 139684 A1 12/2010 OTHER PUBLICATIONS (75) Inventors: Hannah Maria Koenig, Mannheim (DE); Klaus Muellbach, Gruenstadt Edward C. Leonard. “High Polymers'. Wiley-Interscience, A Divi (DE); Matthias Kiefer, Ludwigshafen sion of John Wiley & Sons, Inc., vol. XXIV. (part 2), 1971, 1 front (DE); Sergei V. Kostjuk, Minsk (BY); page, pp. 713-733. 66/ - - - - - Irina Vasilenko, Minsk (BY): James D. Burrington, et al., Cationic polymerization using s s heteropolyacid salt catalysts'. Topics in Catalysis, vol. 23, Nos. 1-4. Alexander Frolov, Svisloch (BY) Aug. 2003, pp. 175-181. Sergei V. Kostjuk, et al., “Novel Initiating system based on AlCl (73) Assignee: BASFSE, Ludwigshafen (DE) etherate for quasiliving cationic polymerization of styrene'. Polymer Bulletin, vol. 52, 2004, pp. 227-234. (*) Notice: Subject to any disclaimer, the term of this Sergei V. Kostjuk, et al., “Cationic Polymerization of Styrene in patent is extended or adjusted under 35 Solution and Aqueous Suspension Using B(C6F5) as a Water-Toler U.S.C. 154(b) by 0 days. ant Lewis Acid', Macromolecules, vol.39, No. 9, Apr. 8, 2006, pp. 3110-3113. (21) Appl. No.: 13/029,413 U.S. Appl. No. 13/126,857, filed Apr. 29, 2011, Hildebrandt, et al. U.S. Appl. No. 13/305,132, filed Nov. 28, 2011, Koenig, et al. (22) Filed: Feb. 17, 2011 U.S. Appl. No. 13/305,283, filed Nov.
    [Show full text]